Canature Health(SZ:300272) Zheng Quan Zhi Xing·2025-09-01 01:20Core Viewpoint - The company is announcing the forced redemption of its convertible bonds ("开能转债") at a price of 100.118 yuan per bond, urging bondholders to convert their bonds into shares before the deadline to avoid potential losses [1][2]. Summary by Sections Convertible Bond Basic Information - The company issued 2.5 million convertible bonds on July 20, 2023, with a total value of 250 million yuan [3]. - The initial conversion price was set at 5.67 yuan per share, which has been adjusted multiple times due to dividend distributions, with the latest adjustment bringing it to 5.36 yuan per share [3][4][5]. Conditional Redemption Terms and Triggering Events - The conditional redemption clause allows the company to redeem the bonds if the stock price exceeds 130% of the conversion price for at least 15 out of 30 consecutive trading days [5][6]. - The stock price reached the threshold of 6.968 yuan per share, triggering the redemption clause between July 21, 2025, and August 11, 2025 [6]. Redemption Implementation Arrangements - The redemption price is confirmed at 100.118 yuan per bond, which includes accrued interest calculated based on a 1.00% coupon rate [6][7]. - The redemption will be executed for all bondholders registered by the close of trading on September 1, 2025, with the redemption funds expected to reach the bondholders' accounts by September 9, 2025 [7][8]. Other Relevant Information - The company has confirmed that there were no transactions of the convertible bonds by major stakeholders in the six months leading up to the redemption conditions being met [8].